peptic ulcer	treated by	proton‑pump inhibitor
GORD	treated by	proton‑pump inhibitor
proton‑pump inhibitor	reduces	gastric acid
gastric acid	causes	ulcer pain
ulcer pain	leads to	patient discomfort
patient discomfort	increases	healthcare visits
healthcare visits	predict	readmission risk
proton‑pump inhibitor	improves	mucosal healing
mucosal healing	reduces	bleeding risk
bleeding risk	predicts	mortality
proton‑pump inhibitor	has	drug interactions
drug interactions	increase	adverse events
adverse events	predict	hospital stay
hospital stay	correlates with	cost
cost	influences	treatment adherence
treatment adherence	affects	relapse rate
relapse rate	predicts	long‑term outcomes
proton‑pump inhibitor	contraindicated in	renal impairment
renal impairment	increases	drug toxicity
drug toxicity	leads to	ICU admission
ICU admission	predicts	mortality
proton‑pump inhibitor	metabolized by	CYP2C19
CYP2C19 polymorphism	affects	drug efficacy
drug efficacy	determines	symptom control
symptom control	predicts	quality of life
quality of life	influences	medication adherence
medication adherence	correlates with	disease remission
disease remission	reduces	healthcare costs
proton‑pump inhibitor	used in	Zollinger‑Ellison syndrome
Zollinger‑Ellison syndrome	characterized by	gastrinoma
gastrinoma	causes	hypergastrinemia
hypergastrinemia	leads to	acid hypersecretion
acid hypersecretion	treated by	high‑dose proton‑pump inhibitor
high‑dose proton‑pump inhibitor	may cause	hypomagnesemia
hypomagnesemia	predicts	arrhythmia
arrhythmia	increases	mortality
proton‑pump inhibitor	used for	GERD prophylaxis
GERD prophylaxis	reduces	esophageal erosion
esophageal erosion	lowers	Barrett’s risk
Barrett’s risk	predicts	esophageal cancer
esophageal cancer	increases	mortality
proton‑pump inhibitor	associated with	bone fracture
bone fracture	predicts	functional decline
functional decline	leads to	institutionalization
institutionalization	raises	caregiver burden
caregiver burden	affects	patient compliance
patient compliance	determines	treatment success
treatment success	predicts	long‑term survival
proton‑pump inhibitor	prescribed with	H2‑receptor antagonist
H2‑receptor antagonist	reduces	rebound acid
rebound acid	causes	symptom recurrence
symptom recurrence	leads to	medication escalation
medication escalation	increases	polypharmacy
polypharmacy	raises	fall risk
fall risk	predicts	hospitalization
hospitalization	correlates with	mortality
proton‑pump inhibitor	has	drug‑drug interaction
drug‑drug interaction	with	clopidogrel
clopidogrel	reduces	antiplatelet effect
antiplatelet effect	lowers	bleeding prevention
bleeding prevention	predicts	cardiovascular events
cardiovascular events	increase	mortality
proton‑pump inhibitor	used for	stress ulcer prophylaxis
stress ulcer prophylaxis	reduces	GI bleeding
GI bleeding	predicts	ICU admission
ICU admission	correlates with	mortality
proton‑pump inhibitor	can cause	C. difficile infection
C. difficile infection	leads to	diarrhea
diarrhea	increases	dehydration risk
dehydration risk	predicts	hospital readmission
hospital readmission	associated with	poor prognosis
proton‑pump inhibitor	has	black box warning
black box warning	indicates	serious adverse events
serious adverse events	predict	mortality
proton‑pump inhibitor	used in	chronic kidney disease
chronic kidney disease	increases	drug accumulation
drug accumulation	causes	toxicity
toxicity	leads to	hospitalization
hospitalization	predicts	mortality
proton‑pump inhibitor	metabolized by	CYP3A4
CYP3A4 inhibition	increases	drug levels
drug levels	raise	adverse events
adverse events	predict	readmission
readmission	correlates with	mortality
proton‑pump inhibitor	used for	erosive esophagitis
erosive esophagitis	improves	mucosal integrity
mucosal integrity	reduces	ulcer recurrence
ulcer recurrence	predicts	long‑term outcomes
long‑term outcomes	influence	survival
proton‑pump inhibitor	associated with	vitamin B12 deficiency
vitamin B12 deficiency	leads to	neuropathy
neuropathy	predicts	functional decline
functional decline	increases	mortality
proton‑pump inhibitor	used in	peptic ulcer disease
peptic ulcer disease	causes	anemia
anemia	predicts	cardiovascular risk
cardiovascular risk	increases	mortality
proton‑pump inhibitor	has	over‑the‑counter availability
over‑the‑counter availability	affects	self‑medication
self‑medication	predicts	medication errors
